🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Nanoscopic Second Look Into the Knee Joint

RecruitingNAAges 18 Years - anyAllAngelina Vera MD
NCT07709819 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to look at how well different surgeries heal over time in patients that have previously undergone arthroscopic knee interventions. These procedures may include cartilage repair or grafting, meniscus repair or trimming, ligament reconstruction, cartilage smoothing, and treatments such as amniotic tissue or platelet rich plasma (PRP). Using a very small camera called a nanoarthroscope, doctors will take a "second look" inside the knee after surgery to see how it has healed. These findings will be compared to patient-reported outcomes, such as pain and function scores, as well as images taken during the original surgery. The goal is to determine whether this second look provides useful information that can help guide recovery and future care.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years and older who have undergone or are scheduled to undergo arthroscopic knee intervention. * Eligible procedures include meniscus repair, biocartilage procedures, and other arthroscopic biologic interventions of the knee * Ability to understand and provide informed consent * Agreement to undergo postoperative in-clinic second-look nanoscopic arthroscopy of the knee. Exclusion Criteria: * Refusal to undergo postoperative in-clinic second-look nanoscopic arthroscopy of the knee. * Inability to provide informed consent. * Individuals who are not yet adults (infants, children, teenagers). * Pregnant women * Prisoners
💊

What it tests

  • Nanoscopic Arthroscopy of the Knee
📍

Where

1 site
University Medical Center of Southern Nevada
Las Vegas, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy